Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results

Strong Service Growth; Debt Refinancing Complete; Company Issues FY26 Guidance MADISON, Wis., Aug. 13, 2025 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2025, ended June 30, 2025. Key Fiscal Fourth Quarter Highlights Net revenue was $127.5 million, a decrease of 5 percent from the prior year period.… Continue reading Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results

CISCO REPORTS FOURTH QUARTER AND FISCAL YEAR 2025 EARNINGS

SAN JOSE, Calif., Aug. 13, 2025 /PRNewswire/ —  News Summary: Strong topline performance at the high end of our guidance ranges: Q4 revenue of $14.7 billion, up 8% year over year FY 2025 revenue of $56.7 billion, up 5% year over year Q4 product orders up 7% year over year with growth across all geographies,… Continue reading CISCO REPORTS FOURTH QUARTER AND FISCAL YEAR 2025 EARNINGS

Jianpu Technology Inc. Announces Ex-dividend Date for Recently Announced Cash Dividend

BEIJING, Aug. 13, 2025 /PRNewswire/ — Jianpu Technology Inc. (“Jianpu,” or the “Company”) (OTCQB: AIJTY), a leading open financial technology platform in China, today announced that FINRA has set September 9, 2025 as the ex-dividend date for the Company’s special cash dividend to be paid in September 2025 that was announced on August 7, 2025. As the… Continue reading Jianpu Technology Inc. Announces Ex-dividend Date for Recently Announced Cash Dividend

Inhibrx Reports Second Quarter 2025 Financial Results

SAN DIEGO, Aug. 13, 2025 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”) today reported financial results for the second quarter of 2025. Following the completion of the sale of INBRX-101 (the “101 Transaction”) by Inhibrx, Inc. (the “Former Parent”) to Sanofi S.A. and the Former Parent’s concurrent spin-off of the Inhibrx business… Continue reading Inhibrx Reports Second Quarter 2025 Financial Results

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

Announced positive data from the Phase 1 clinical trial of ELVN-001 in CML, reporting a cumulative MMR rate of 47% with 32% of patients achieving MMR by 24 weeks and demonstrating a favorable safety and tolerability profile across all dose levels Strong balance sheet with $491 million in cash, cash equivalents and marketable securities, which… Continue reading Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

Century Communities Announces Quarterly Cash Dividend

GREENWOOD VILLAGE, Colo., Aug. 13, 2025 /PRNewswire/ — Century Communities, Inc. (NYSE: CCS), one of the nation’s largest homebuilders, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share. This dividend is payable on September 10, 2025 to stockholders of record as of the close of business on August… Continue reading Century Communities Announces Quarterly Cash Dividend

Inc. 5000 Names Tiny Tags, Celebrity-Loved Personalized Jewelry Brand, Among America’s Fastest-Growing Private Companies for Third Time

Founder-built, female-founded company has over 50% revenue growth and multi-channel expansion  NEW YORK, Aug. 13, 2025 /PRNewswire/ — Tiny Tags, the celebrity-loved personalized jewelry brand, has earned a coveted spot on the Inc. 5000 list for the third time in four years, ranking #2579 among America’s fastest-growing private companies. The female-founded, self-funded multi-million-dollar company achieved… Continue reading Inc. 5000 Names Tiny Tags, Celebrity-Loved Personalized Jewelry Brand, Among America’s Fastest-Growing Private Companies for Third Time

Ironclad Announces Strategic Partnership with Harvey

The new partnership will connect Ironclad’s leading AI CLM with Harvey’s advanced legal AI to accelerate legal workflows for mutual customers SAN FRANCISCO, Aug. 13, 2025 /PRNewswire/ — Ironclad, the leading AI contract lifecycle management (CLM) platform, today announced it has entered into a strategic partnership with Harvey, the company building domain-specific AI for legal… Continue reading Ironclad Announces Strategic Partnership with Harvey

Nursing Homes See Measurable Results and Rising Excitement Over Advanced AI Tool from Long-Term Care Tech Firm

CMI.ai by Blue Purpose — the first AI solution within the VIBE platform built to master complex reimbursement rules nationwide, delivering real-time detection, state-specific scoring, and actionable insights that drive measurable outcomes for long-term care providers. TAMPA, Fla., Aug. 13, 2025 /PRNewswire/ — Blue Purpose, the innovative technology company behind the award-winning VIBE platform, today… Continue reading Nursing Homes See Measurable Results and Rising Excitement Over Advanced AI Tool from Long-Term Care Tech Firm

Supreme Court reserves judgement on JSW’s $2.3 Bn Bhushan Steel bid

The high-stakes legal battle, heard on August 7th, 8th, and 11th, 2025, involved intricate interpretations of India’s Insolvency and Bankruptcy Code. India’s Supreme Court concluded hearings this week in a contentious case over JSW Steel’s $2.3 billion bid to acquire Bhushan Power & Steel Ltd (BPSL) through India’s bankruptcy mechanism, with the judgment now reserved.… Continue reading Supreme Court reserves judgement on JSW’s $2.3 Bn Bhushan Steel bid